Previous 10 | Next 10 |
home / stock / sny / sny articles
After the first week of earnings, analysts have tempered their expectations for profit growth, anticipating a continuation of the profit-decli...
As the respiratory virus season kicks off, healthcare providers are racing against time to offer Pfizer Inc's (NYSE: PFE) vaccine, Ab...
According to a report on Thursday, French pharma company Sanofi SA (NASDAQ: SNY) is reportedly exploring a potential acquisition of cance...
Benzinga AI Powerhouse: Palantir And PwC Team Up To Accelerate Data-Driven Operations Palantir Technologies Inc (NYSE: PLTR) is expanding its...
Sanofi SA (NASDAQ: SNY) and Teva Pharmaceutical Industries Ltd (NYSE: TEVA) have collaborated to co-develop and co-commercializ...
Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment TEV'574, a novel anti-TL1A therapy, is bei...
Benzinga Microsoft's Nadella Criticizes Google's Exclusive Content Deals Amid Antitrust Case In a significant development, Microsoft ...
Sanofi SA (NASDAQ: SNY) struck a deal with Janssen Pharmaceuticals, a unit of Johnson & Johnson (NYSE: JNJ), to develop and...
AstraZeneca Plc (NASDAQ: AZN) has agreed to pay $425 million to settle U.S. lawsuits related to heartburn and stomach acid treatment...
News, Short Squeeze, Breakout and More Instantly...
Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns. ...
2024-07-09 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...